Jushi Holdings Inc. (JUSH): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$35.84M
Year ended 2025-12-31
$37.58M
Trailing 12 months to 2026-06-30
$40.75M2020-12-31: -$12.13M2021-12-31: -$27.35M2022-12-31: -$193.84M2023-12-31: $23.77M2024-12-31: $40.75M2025-12-31: $35.84M$35.84M
2020-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$35.84M-12.1%2026-03-31, From 2025-01-01
2024-12-31$40.75M+71.4%2026-03-31, From 2024-01-01
2023-12-31$23.77Mn/m2026-03-31, From 2023-01-01
2022-12-31-$193.84Mn/m2024-04-01, From 2022-01-01
2021-12-31-$27.35Mn/m2024-04-01, From 2021-01-01
2020-12-31-$12.13Mn/a2023-04-18, From 2020-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Jushi Holdings Inc. (JUSH)2025-12-31$35.84M-12.1%
biote Corp. (BTMD)2025-12-31$39.22M+11.5%
Glass House Brands Inc. (GLAS)2025-12-31-$1.53Mn/m
Marimed Inc. (MRMD)2025-12-31$5.29M-49.7%
Cronos Group Inc. (CRON)2025-12-31-$3.16Mn/m
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$56.52M-20.3%
Natural Alternatives International Inc (NAII)2025-06-30-$4.10Mn/m
Mannatech Inc (MTEX)2025-12-31$666.0K-77.5%
Cresco Labs Inc. (CRLBF)2025-12-31$20.73M-87.5%

Compare JUSH, BTMD, GLAS, MRMD side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗